Literature DB >> 21564097

Casein kinase 1 enables nucleus accumbens amphetamine-induced locomotion by regulating AMPA receptor phosphorylation.

Dongdong Li1, Stacy Herrera, Nancy Bubula, Elena Nikitina, Abraham A Palmer, Dorothy A Hanck, Jessica A Loweth, Paul Vezina.   

Abstract

The closely related δ and ε isoforms of the serine/threonine protein kinase casein kinase 1 (Csnk1) have been implicated in the generation of psychostimulant-induced behaviors. In this study, we show that Csnk1δ/ε produces its effects on behavior by acting on the Darpp-32-PP1 signaling pathway to regulate AMPA receptor phosphorylation in the nucleus accumbens (NAcc). Inhibiting Csnk1δ/ε in the NAcc with the selective inhibitor PF-670462 blocks amphetamine induced locomotion and its ability to increase phosphorylation of Darpp-32 at S137 and T34, decrease PP1 activity and increase phosphorylation of the AMPA receptor subunit at S845. Consistent with these findings, preventing GluR1 phosphorylation with the alanine mutant GluR1(S845A) reduces glutamate-evoked currents in cultured medium spiny neurons and blocks the locomotor activity produced by NAcc amphetamine. Thus, Csnk1 enables the locomotor and likely the incentive motivational effects of amphetamine by regulating Darrp-32-PP1-GlurR1(S845) signaling in the NAcc. As such, Csnk1 may be a critical target for intervention in the treatment of drug use disorders.
© 2011 The Authors. Journal of Neurochemistry © 2011 International Society for Neurochemistry.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21564097      PMCID: PMC3129449          DOI: 10.1111/j.1471-4159.2011.07308.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  46 in total

1.  Regulation of phosphorylation of the GluR1 AMPA receptor in the neostriatum by dopamine and psychostimulants in vivo.

Authors:  G L Snyder; P B Allen; A A Fienberg; C G Valle; R L Huganir; A C Nairn; P Greengard
Journal:  J Neurosci       Date:  2000-06-15       Impact factor: 6.167

2.  Subunit-specific rules governing AMPA receptor trafficking to synapses in hippocampal pyramidal neurons.

Authors:  S Shi; Y Hayashi; J A Esteban; R Malinow
Journal:  Cell       Date:  2001-05-04       Impact factor: 41.582

3.  Physiological role for casein kinase 1 in glutamatergic synaptic transmission.

Authors:  Karima Chergui; Per Svenningsson; Paul Greengard
Journal:  J Neurosci       Date:  2005-07-13       Impact factor: 6.167

4.  Sensitivity to psychostimulants in mice bred for high and low stimulation to methamphetamine.

Authors:  H M Kamens; S Burkhart-Kasch; C S McKinnon; N Li; C Reed; T J Phillips
Journal:  Genes Brain Behav       Date:  2005-03       Impact factor: 3.449

Review 5.  The neurobiology of slow synaptic transmission.

Authors:  P Greengard
Journal:  Science       Date:  2001-11-02       Impact factor: 47.728

6.  Sensitized increase of period gene expression in the mouse caudate/putamen caused by repeated injection of methamphetamine.

Authors:  T Nikaido; M Akiyama; T Moriya; S Shibata
Journal:  Mol Pharmacol       Date:  2001-04       Impact factor: 4.436

7.  Regulation of cyclin-dependent kinase 5 and casein kinase 1 by metabotropic glutamate receptors.

Authors:  F Liu; X H Ma; J Ule; J A Bibb; A Nishi; A J DeMaggio; Z Yan; A C Nairn; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

8.  Reinsertion or degradation of AMPA receptors determined by activity-dependent endocytic sorting.

Authors:  M D Ehlers
Journal:  Neuron       Date:  2000-11       Impact factor: 17.173

9.  Reduction of cocaine place preference in mice lacking the protein phosphatase 1 inhibitors DARPP 32 or Inhibitor 1.

Authors:  Venetia Zachariou; Marianne Benoit-Marand; Patrick B Allen; Peter Ingrassia; Allen A Fienberg; Francois Gonon; Paul Greengard; Marina R Picciotto
Journal:  Biol Psychiatry       Date:  2002-04-15       Impact factor: 13.382

10.  Mechanism of regulation of casein kinase I activity by group I metabotropic glutamate receptors.

Authors:  Feng Liu; David M Virshup; Angus C Nairn; Paul Greengard
Journal:  J Biol Chem       Date:  2002-09-09       Impact factor: 5.157

View more
  21 in total

1.  Association between a casein kinase 1 ε gene polymorphism and schizophrenia in a Chinese Han population.

Authors:  Yinglin Huang; Jingying Li; Lijuan Wu; Qiu Jin; Xiaofeng Zhao; Jun Li; Gang Zhu
Journal:  J Mol Neurosci       Date:  2012-02-25       Impact factor: 3.444

2.  Nucleus accumbens AMPA receptor involvement in cocaine-conditioned place preference under different dietary conditions in rats.

Authors:  Danielle Zheng; Soledad Cabeza de Vaca; Zachary Jurkowski; Kenneth D Carr
Journal:  Psychopharmacology (Berl)       Date:  2015-01-16       Impact factor: 4.530

3.  An inhibitor of casein kinase 1 ε/δ partially normalizes the manic-like behaviors of the ClockΔ19 mouse.

Authors:  Rachel Arey; Colleen A McClung
Journal:  Behav Pharmacol       Date:  2012-08       Impact factor: 2.293

4.  Dynamic increases in AMPA receptor phosphorylation in the rat hippocampus in response to amphetamine.

Authors:  Li-Min Mao; Bing Xue; Dao-Zhong Jin; John Q Wang
Journal:  J Neurochem       Date:  2015-03-02       Impact factor: 5.372

5.  Casein kinase 1-epsilon deletion increases mu opioid receptor-dependent behaviors and binge eating1.

Authors:  L R Goldberg; S L Kirkpatrick; N Yazdani; K P Luttik; O A Lacki; R K Babbs; D F Jenkins; W E Johnson; C D Bryant
Journal:  Genes Brain Behav       Date:  2017-07-06       Impact factor: 3.449

6.  Dopaminergic pathway polymorphisms and heroin addiction: further support for association of CSNK1E variants.

Authors:  Orna Levran; Einat Peles; Matthew Randesi; Joel Correa da Rosa; Jurg Ott; John Rotrosen; Miriam Adelson; Mary Jeanne Kreek
Journal:  Pharmacogenomics       Date:  2014-12       Impact factor: 2.533

7.  Csnk1e is a genetic regulator of sensitivity to psychostimulants and opioids.

Authors:  Camron D Bryant; Clarissa C Parker; Lili Zhou; Christopher Olker; Ramalakshmi Y Chandrasekaran; Travis T Wager; Valerie J Bolivar; Andrew S Loudon; Martha H Vitaterna; Fred W Turek; Abraham A Palmer
Journal:  Neuropsychopharmacology       Date:  2011-11-16       Impact factor: 7.853

Review 8.  Structure, regulation, and (patho-)physiological functions of the stress-induced protein kinase CK1 delta (CSNK1D).

Authors:  Pengfei Xu; Chiara Ianes; Fabian Gärtner; Congxing Liu; Timo Burster; Vasiliy Bakulev; Najma Rachidi; Uwe Knippschild; Joachim Bischof
Journal:  Gene       Date:  2019-07-31       Impact factor: 3.688

9.  Locomotor conditioning by amphetamine requires cyclin-dependent kinase 5 signaling in the nucleus accumbens.

Authors:  Bryan F Singer; Nichole M Neugebauer; Justin Forneris; Kelli R Rodvelt; Dongdong Li; Nancy Bubula; Paul Vezina
Journal:  Neuropharmacology       Date:  2014-06-02       Impact factor: 5.250

10.  Rapid and sustained GluA1 S845 phosphorylation in synaptic and extrasynaptic locations in the rat forebrain following amphetamine administration.

Authors:  Bing Xue; Matthew C Edwards; Li-Min Mao; Ming-Lei Guo; Dao-Zhong Jin; Eugene E Fibuch; John Q Wang
Journal:  Neurochem Int       Date:  2013-11-11       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.